or cheaper medications that are biologically similar to more expensive options on the market. As of 2023, beta cell regeneration and Immunotherapy are two potentially new treatments for diabetes ...

Removing the highly popular diabetes and obesity medications from the shortage list could limit options for patients who ...

Senator Bernie Sanders said that he had written commitments from major PBMs to protect access to the drugs if the list price ...

If you double up on your dose, it is possible to overdose on Ozempic. Here's what to know—including side effects and what to ...

Another benefit from a recycling program would be information about why patients prematurely stop their medication ... for chronic indications such as diabetes, hypertension, dyslipidemia ...

A large trial showed that semaglutide, sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current ...

She first learned of the shortage on the social media app, where it has pitted diabetes patients ... as important as a medication being either prohibitively expensive, or just out of supply ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a shortage of the brand-name drug has ended – which means compounding of the ...